Virtual Management of Rheumatoid Arthritis
ePRAT
Evaluation of Rheumatoid Arthritis at the Time of Telemedicine
1 other identifier
observational
70
1 country
1
Brief Summary
The purpose of this study is to optimize the care of patients with RA seen in virtual consultation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2021
CompletedFirst Posted
Study publicly available on registry
November 18, 2021
CompletedStudy Start
First participant enrolled
November 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 22, 2023
CompletedSeptember 15, 2025
September 1, 2025
2 years
October 22, 2021
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of face to face consultation, hospitalization and therapeutic modifications
The primary outcome will be the rate of face to face consultation, hospitalization and therapeutic modifications decided by the rheumatologist during the virtual consultation
Inclusion
Study Arms (1)
Patients with rheumatoid arthritis
Patients seen in virtual consultation
Interventions
Rheumatoid Arthritis Impact of Disease questionnaire
Eligibility Criteria
Patients with rheumatoid arthritis followed in a tertiary center (University Hospital Cochin)
You may qualify if:
- Patients with rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria
- Follow-up in the rheumatology department of Cochin Hospital
- Affiliated with a social security scheme
- Non-opposition to participating in the study
- Patients with a valid email address (registration to the virtual consultation system)
You may not qualify if:
- Opposition to participate to this research
- Inability to understand or speak French
- Patient under tutor or curator ship
- patients under medical state help
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rheumatology Department, Cochin Hospital
Paris, IDF, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jérôme AVOUAC, MD, PhD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2021
First Posted
November 18, 2021
Study Start
November 30, 2021
Primary Completion
November 22, 2023
Study Completion
November 22, 2023
Last Updated
September 15, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share